176 related articles for article (PubMed ID: 17177280)
1. Blood bank issues associated with red cell exchanges in sickle cell disease.
Sarode R; Altuntas F
J Clin Apher; 2006 Dec; 21(4):271-3. PubMed ID: 17177280
[TBL] [Abstract][Full Text] [Related]
2. Predicting the effect of transfusing only phenotype-matched RBCs to patients with sickle cell disease: theoretical and practical implications.
Castro O; Sandler SG; Houston-Yu P; Rana S
Transfusion; 2002 Jun; 42(6):684-90. PubMed ID: 12147019
[TBL] [Abstract][Full Text] [Related]
3. Antigen matching for transfusion support in Brazilian female patients with sickle cell disease to reduce RBC alloimmunization.
Muniz JG; Arnoni C; Medeiros R; Vendrame T; Cortez A; S Afonso J; Latini F; Castilho L; Girão M
Transfusion; 2021 Aug; 61(8):2458-2467. PubMed ID: 34121200
[TBL] [Abstract][Full Text] [Related]
4. Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease.
Talano JA; Hillery CA; Gottschall JL; Baylerian DM; Scott JP
Pediatrics; 2003 Jun; 111(6 Pt 1):e661-5. PubMed ID: 12777582
[TBL] [Abstract][Full Text] [Related]
5. Red blood cell alloimmunization in sickle cell disease: prevalence in 2010.
Miller ST; Kim HY; Weiner DL; Wager CG; Gallagher D; Styles LA; Dampier CD; Roseff SD;
Transfusion; 2013 Apr; 53(4):704-9. PubMed ID: 22804353
[TBL] [Abstract][Full Text] [Related]
6. Antigen-matched red blood cell transfusions for patients with sickle cell disease at The Johns Hopkins Hospital.
Karafin MS; Shirey RS; Ness PM; King KE
Immunohematology; 2012; 28(1):3-6. PubMed ID: 22646142
[No Abstract] [Full Text] [Related]
7. Comparative study of alloimmunization against red cell antigens in sickle cell disease & thalassaemia major patients on regular red cell transfusion.
Jariwala K; Mishra K; Ghosh K
Indian J Med Res; 2019 Jan; 149(1):34-40. PubMed ID: 31115372
[TBL] [Abstract][Full Text] [Related]
8. Safety and benefits of automated red cell depletion-exchange compared to standard exchange in patients with sickle cell disease undergoing chronic transfusion.
Ziemba Y; Xu C; Fomani KM; Nandi V; Yuan T; Rehmani S; Sachais BS; Appiah-Kubi AO; Aygun B; Louie JE; Shi PA
Transfusion; 2021 Feb; 61(2):526-536. PubMed ID: 33368343
[TBL] [Abstract][Full Text] [Related]
9. High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors.
Chou ST; Jackson T; Vege S; Smith-Whitley K; Friedman DF; Westhoff CM
Blood; 2013 Aug; 122(6):1062-71. PubMed ID: 23723452
[TBL] [Abstract][Full Text] [Related]
10. Red blood cell exchange in patients with sickle cell disease-indications and management: a review and consensus report by the therapeutic apheresis subsection of the AABB.
Biller E; Zhao Y; Berg M; Boggio L; Capocelli KE; Fang DC; Koepsell S; Music-Aplenc L; Pham HP; Treml A; Weiss J; Wool G; Baron BW
Transfusion; 2018 Aug; 58(8):1965-1972. PubMed ID: 30198607
[TBL] [Abstract][Full Text] [Related]
11. Challenges in preventing and treating hemolytic complications associated with red blood cell transfusion.
Chonat S; Arthur CM; Zerra PE; Maier CL; Jajosky RP; Yee MEM; Miller MJ; Josephson CD; Roback JD; Fasano R; Stowell SR
Transfus Clin Biol; 2019 May; 26(2):130-134. PubMed ID: 30979566
[TBL] [Abstract][Full Text] [Related]
12. Phenotype matching of donor red blood cell units for nonalloimmunized sickle cell disease patients: a survey of 1182 North American laboratories.
Osby M; Shulman IA
Arch Pathol Lab Med; 2005 Feb; 129(2):190-3. PubMed ID: 15679419
[TBL] [Abstract][Full Text] [Related]
13. Impact of Red Blood Cell Antigen Matching on Alloimmunization and Transfusion Complications in Patients with Sickle Cell Disease: A Systematic Review.
Fasano RM; Meyer EK; Branscomb J; White MS; Gibson RW; Eckman JR
Transfus Med Rev; 2019 Jan; 33(1):12-23. PubMed ID: 30122266
[TBL] [Abstract][Full Text] [Related]
14. The prevention and management of alloimmunization in sickle cell disease: the benefit of extended phenotypic matching of red blood cells.
Vichinsky EP
Immunohematology; 2012; 28(1):20-3. PubMed ID: 22646146
[No Abstract] [Full Text] [Related]
15. Transfusion therapy for sickle cell disease: a balancing act.
Chou ST
Hematology Am Soc Hematol Educ Program; 2013; 2013():439-46. PubMed ID: 24319217
[TBL] [Abstract][Full Text] [Related]
16. Transfusion of multiple units of Js(b+) red blood cells in the presence of anti-Jsb in a patient with sickle beta-thalassemia disease and a review of the literature.
Yuan S; Ewing NP; Bailey D; Salvador M; Wang S
Immunohematology; 2007; 23(2):75-80. PubMed ID: 18004938
[TBL] [Abstract][Full Text] [Related]
17. Directed blood donor program decreases donor exposure for children with sickle cell disease requiring chronic transfusion.
Roberts DO; Covert B; Lindsey T; Edwards V; McLaughlin L; Theus J; Wray RJ; Jupka K; Baker D; Robbins M; DeBaun MR
Immunohematology; 2012; 28(1):7-12. PubMed ID: 22646143
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of prospective red blood cell antigen matching to prevent alloimmunization among sickle cell patients.
Kacker S; Ness PM; Savage WJ; Frick KD; Shirey RS; King KE; Tobian AA
Transfusion; 2014 Jan; 54(1):86-97. PubMed ID: 23692415
[TBL] [Abstract][Full Text] [Related]
19. The future of red blood cell alloimmunization risk reduction.
Kacker S; Ness PM; Shirey RS; Savage WJ; King KE; Tobian AA
Transfusion; 2015 Jan; 55(1):222-4. PubMed ID: 25582240
[No Abstract] [Full Text] [Related]
20. The future of red blood cell alloimmunization risk reduction.
Karafin MS; Denomme GA; Bryant BJ
Transfusion; 2015 Jan; 55(1):220-1. PubMed ID: 25582238
[No Abstract] [Full Text] [Related]
[Next] [New Search]
